Psychedelic Business News Spotlight: December 10, 2020
This week in psychedelic business news: Motley Fool bets on MindMed, mushrooms go from Jamaica to Canada, and more.
About Jill Ettinger
Jill Ettinger is a Los Angeles-based writer and editor immersed in digital publishing and storytelling with a focus on the global food and wellness systems and how they intersect with our cultural traditions, ethics, and politics. Her work has been featured in The Huffington Post, MTV, and the Village Voice.
Entries by
Interview with Kelli Foulkrod
December 9, 2020 /0 Comments/by Jill EttingerPsychedelic Life Science Company Cybin Acquires Ketamine Drug Maker Adelia Therapeutics
Cybin Inc., has acquired the ketamine drug Spravato manufacturer Adelia Therapeutics in its first major acquisition.
Adele LaFrance: Healing Eating Disorders With Psychedelics
Clinical psychologist Adele LaFrance is working with psychedelics like ayahuasca to help treat eating disorders.
Interview with Ian McCall
December 7, 2020 /0 Comments/by Jill EttingerInterview with Hadas Alterman
December 3, 2020 /0 Comments/by Jill EttingerPsychedelic Business News Spotlight: December 3, 2020
December 3, 2020 /0 Comments/by Jill EttingerInterview with Amber Amendola
December 3, 2020 /0 Comments/by Jill EttingerMike Tyson Credits 5-MeO for His Return to Boxing
November 30, 2020 /0 Comments/by Jill EttingerPeter Thiel Invests $12 Million In Psychedelic Drug Manufacturer
November 25, 2020 /0 Comments/by Jill EttingerPsychedelic Spotlight
Psychedelic Spotlight is your reliable source for the latest stories in the emerging psychedelics industry, covering breakthrough discoveries, investor news and cultural reform.
